Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management
What This Means for Women in Midlife If you're considering a GLP-1 medication for weight management, the question isn't just "which medication?" it's "what else is going on hormonally?" For women in perimenopause or postmenopause, addressing estrogen deficiency may: Enhance the weight loss response to GLP-1 medications [1] Improve the metabolic benefits including better insulin sensitivity and reduced visceral fat [7, 8] Address symptoms like sleep disruption, hot flashes, and mood changes that can undermine weight loss efforts [10] Support long-term cardiovascular health during a period of accelerated risk [9] This is why a comprehensive approach one that evaluates both your metabolic health and your hormonal status matters so much more than choosing a single medication in isolation
As mentioned, drinking plenty of water throughout the day is good for weight loss and overall health
Es ist wichtig, dass die Behandlung unter rztlicher Aufsicht erfolgt, um eine angemessene Dosierung sicherzustellen und mgliche Nebenwirkungen zu berwachen
